- Global Cancer Incidence and Screening
- BRCA gene mutations in cancer
- Cancer Risks and Factors
- Cancer survivorship and care
- Patient-Provider Communication in Healthcare
- Health Literacy and Information Accessibility
- Nutrition, Genetics, and Disease
- Cancer-related cognitive impairment studies
- Gastric Cancer Management and Outcomes
- Legume Nitrogen Fixing Symbiosis
- Soil Carbon and Nitrogen Dynamics
- Family and Disability Support Research
- Health, psychology, and well-being
- Economic and Financial Impacts of Cancer
- Genetic factors in colorectal cancer
- Health Systems, Economic Evaluations, Quality of Life
- Healthcare cost, quality, practices
- Cancer Genomics and Diagnostics
- Family Support in Illness
- Colorectal Cancer Screening and Detection
- Ruminant Nutrition and Digestive Physiology
- Lymphatic System and Diseases
- Colorectal Cancer Surgical Treatments
- Autism Spectrum Disorder Research
- Ethics in Clinical Research
Murdoch University
2023
Tohoku University
2021
Tokyo Metropolitan University
2021
Suzuki (Japan)
2021
The Japanese Society of Gastroenterological Surgery
2021
Hudson Institute
2021
University of Stirling
2017-2019
The University of Melbourne
2013-2018
Peter MacCallum Cancer Centre
2015-2018
Victorian Comprehensive Cancer Centre
2018
Decision support tools for the assessment and management of breast cancer risk may improve uptake prevention strategies. End-user input in design such is critical to increase clinical use. Before developing a computerized tool, we examined clinicians' practice future needs. Twelve surgeons, 12 primary care physicians 5 nurses participated 4 focus groups. These were recorded, coded, analyzed identify key themes. Participants identified difficulties assessing risk, including lack available...
We aimed to develop a user-centered, web-based, decision support tool for breast cancer risk assessment and personalized management. Using novel model choice algorithm, iPrevent® selects one of two validated estimation models (IBIS or BOADICEA), based on factor data entered by the user. Resulting estimates are presented in simple language graphic formats easy comprehension. then presents risk-adapted, evidence-based, guideline-endorsed management options. Development was an iterative process...
Fear of cancer recurrence (FCR) in people with breast affects treatment recovery, quality life, service utilisation and relationships. Our aim was to investigate how specialist nurses (SBCN) respond their patients' fears analyse SBCN's views about embedding a new psychological intervention, the Mini-AFTERc, into consultations.A mixed methods sequential design used, informed by normalisation process theory. Phase 1: UK SBCNs were emailed web-based survey survivors' FCR is currently identified...
To capitalise on advances in breast cancer prevention, all women would need to have their risk formally assessed. With ~85% of Australians attending primary care clinics at least once a year, is an opportune location for formal assessment and management. This study assessed the current practice needs clinicians regarding management risk. Two facilitated focus group discussions were held with 17 (12 GPs 5 nurses (PNs)) as part larger assessment. Primary viewed cardiovascular intrinsic,...
iPrevent estimates breast cancer (BC) risk and provides tailored management information.
There is limited research on why some individuals who have undergone predictive genetic testing for Lynch syndrome do not adhere to screening recommendations. This study aimed explore qualitatively how non-carriers and carriers translate risk information advice decisions about managment behaviours in the Australian healthcare system. Participants of Australasian Colorectal Cancer Family Registry had were interviewed their management behaviours. Transcripts analysed thematically using a...
Fear of recurrence (FoR) is a major concern for patients following treatment primary breast cancer, affecting 60–99% cancer survivors. Mini-AFTER brief intervention developed to address this fear, that care nurses are ideally placed deliver. However, their interest in delivering such an unknown and crucial its introduction. This study aims assess the perceived feasibility telephone implementation by manage moderate levels fear among A sequential explanatory mixed-methods design will be used,...
To ascertain individual experiences of extended bowel resection as treatment for colorectal cancer (CRC) in those with a high metachronous CRC risk, including the self-reported adequacy information received at different time points and recovery. .Qualitative. .Participants were recruited through Australasian Colorectal Cancer Family Registry two hospitals Melbourne, Australia. .18 individuals risk who had an from 6-12 months ago. .Semistructured interviews. Data analyzed thematically. .In...
The present study aims to provide insight into the interactions between clinical geneticists and parents of children with dysmorphic features during syndrome assessment. Seven families attending a dysmorphology clinic for assessment consented have their consultation recorded transcribed verbatim. Content discourse analyses were used language communication patterns problematic challenging sections consultations, primarily concerning child's appearance diagnosis which marked by dysfluency...
Abstract Aim To give evidence around the acceptability of a proposed randomized controlled trial (RCT) catheter washout solutions. Design A sample senior community nursing staff ( N = 7) were interviewed, and four focus groups with nurses conducted. Eleven semi‐structured face‐to‐face interviews undertaken patients using long‐term catheter. Methods An in‐depth qualitative study phenomenological approach was employed. This suitable to explore lived experiences gain their viewpoints...
1559 Background: Routine assessment of breast cancer (BC) risk by primary care clinicians (PCCs) might improve uptake BC prevention and screening interventions, thus reducing morbidity mortality as has occurred for cardiovascular (CV) disease. Methods: Australian PCCs were recruited through local professional networks. Facilitated focus group discussions about current practice assessing managing audiotaped, transcribed verbatim managed using QSR NVivo qualitative data management software. A...
e20660 Background: End user input into the design of decision support tools is critical to enhance integration and future routine use in clinical practice. As part development an evidence-based, tailored, computerized breast cancer (BC) risk assessment management tool, we examined clinicians’ requirements. Methods: Australian surgeons (BSs) primary care clinicians (PCCs) were recruited through local professional networks. Facilitated focus group discussions about current practice assessing...
17 Background: Routine assessment of breast cancer (BC) risk by primary care clinicians (PCCs) might improve uptake prevention and screening interventions thus reduce morbidity mortality. Methods: Australian PCCs were recruited through local professional networks. Facilitated focus group discussions about current practice assessing managing BC audiotaped, transcribed verbatim managed using QSR NVivo qualitative data management software. A coding framework was developed based on the...
Abstract Background: iPrevent estimates an individual's personal BC risk, using either the IBIS or BOADICEA algorithms, and provides tailored risk management information on screening, lifestyle modifications, risk-reducing surgery medication. It is designed to be used collaboratively by women their clinicians. The purpose of this pre-implementation pilot study was assess clinical usability acceptability prototype, identify barriers implementation. Exploratory aims investigated patients'...
<sec> <title>BACKGROUND</title> iPrevent estimates breast cancer (BC) risk and provides tailored management information. </sec> <title>OBJECTIVE</title> The objective of this study was to assess the usability acceptability prototype. <title>METHODS</title> Clinicians were eligible for participation in if they worked primary care, surgery, or genetics clinics. Female patients aged 18-70 years with no personal history eligible. first familiarized using hypothetical paper-based cases then actor...